FluoSphera SA

FluoSphera has developed in vitro human biosystems that mimic essential features of human body organization. FluoSphera's biosystems generate data that predict much better the effects of drugs on patients, thus reducing the costs of drug development failure up to several hundreds of million dollars per drug. Using this technology, FluoSphera proposes R&D services to pharmaceutical companies willing to de-risk drug development projects. Drug profiling with our biosystems allows the discovery of more efficient drugs for the patients, with less adverse side effects, and it contributes to reduce animal experimentation.